Literature DB >> 7669564

Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastases.

Z S Zeng1, J G Guillem.   

Abstract

The matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) are perceived as essential for tumour invasion and metastasis. In the present study, we compare the topographical pattern of MMP-9 and TIMP-1 expression in colorectal cancer and liver metastasis by in situ hybridisation. TIMP-1 mRNA was detected in all 26 colorectal cancers examined, while only 18 out of 26 (69.2%) were positive for MMP-9. Both MMP-9 and TIMP-1 mRNA were observed in all ten liver metastases but were absent in three adenomas and in all normal colonic mucosa and liver. There was no association between MMP-9 or TIMP-1 mRNA expression and degree of differentiation or size of Tumours. MMP-9 and TIMP-1 mRNA were similarly observed in the peritumour stroma cells rather than in tumour cells themselves. MMP-9 mRNA positive cells were round and identified as macrophages by immunostaining with an anti-macrophage antibody (KP1), while TIMP-1, mRNA was detected in spindle-shaped stromal cells. In liver metastases, MMP-9 localised within peritumour stroma or at the interface between the tumour stroma and normal liver, whereas TIMP-1 mRNA was located throughout the malignant tumour stroma. Our data demonstrate a distinct pattern of MMP-9 and TIMP-1 mRNA expression in colorectal cancer and liver metastases suggesting distinct cellular origins as well as separate patterns of regulation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7669564      PMCID: PMC2033901          DOI: 10.1038/bjc.1995.376

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  46 in total

1.  Matrix vesicles contain metalloproteinases that degrade proteoglycans.

Authors:  D D Dean; Z V Schwartz; O E Muniz; R Gomez; L D Swain; D S Howell; B D Boyan
Journal:  Bone Miner       Date:  1992-05

2.  Association between expression of activated 72-kilodalton gelatinase and tumor spread in non-small-cell lung carcinoma.

Authors:  P D Brown; R E Bloxidge; N S Stuart; K C Gatter; J Carmichael
Journal:  J Natl Cancer Inst       Date:  1993-04-07       Impact factor: 13.506

3.  Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum.

Authors:  T Hayakawa; K Yamashita; K Tanzawa; E Uchijima; K Iwata
Journal:  FEBS Lett       Date:  1992-02-17       Impact factor: 4.124

4.  Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion.

Authors:  B Davies; J Waxman; H Wasan; P Abel; G Williams; T Krausz; D Neal; D Thomas; A Hanby; F Balkwill
Journal:  Cancer Res       Date:  1993-11-15       Impact factor: 12.701

5.  A new inhibitor of metalloproteinases from chicken: ChIMP-3. A third member of the TIMP family.

Authors:  N Pavloff; P W Staskus; N S Kishnani; S P Hawkes
Journal:  J Biol Chem       Date:  1992-08-25       Impact factor: 5.157

6.  Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer.

Authors:  C Pyke; E Ralfkiaer; K Tryggvason; K Danø
Journal:  Am J Pathol       Date:  1993-02       Impact factor: 4.307

7.  Expression of interstitial collagenase, 92-kDa gelatinase, and tissue inhibitor of metalloproteinases-1 in granuloma annulare and necrobiosis lipoidica diabeticorum.

Authors:  U K Saarialho-Kere; E S Chang; H G Welgus; W C Parks
Journal:  J Invest Dermatol       Date:  1993-03       Impact factor: 8.551

8.  Immunohistochemical analysis of type IV collagenase expression in prostatic hyperplasia and adenocarcinoma.

Authors:  A H Boag; I D Young
Journal:  Mod Pathol       Date:  1993-01       Impact factor: 7.842

9.  Activity of type IV collagenases in benign and malignant breast disease.

Authors:  B Davies; D W Miles; L C Happerfield; M S Naylor; L G Bobrow; R D Rubens; F R Balkwill
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640

10.  Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomas.

Authors:  S J Urbanski; D R Edwards; A Maitland; K J Leco; A Watson; A E Kossakowska
Journal:  Br J Cancer       Date:  1992-12       Impact factor: 7.640

View more
  24 in total

1.  Matrix metalloproteinases in gastrointestinal cancer.

Authors:  P D Brown
Journal:  Gut       Date:  1998-08       Impact factor: 23.059

Review 2.  Cell surface molecules and their prognostic values in assessing colorectal carcinomas.

Authors:  J Haier; M Nasralla; G L Nicolson
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

3.  Influence of Stromal Components on Lung Cancer Carcinogenesis.

Authors:  Laurie A Shuman Moss; William G Stetler-Stevenson
Journal:  J Carcinog Mutagen       Date:  2013-06-25

4.  Matrix metalloproteinase-9, -10, and -12, MDM2 and p53 expression in mouse liver during dimethylnitrosamine-induced oxidative stress and genomic injury.

Authors:  Ismail Syed; Jasmine Rathod; Mayur Parmar; George B Corcoran; Sidhartha D Ray
Journal:  Mol Cell Biochem       Date:  2012-03-23       Impact factor: 3.396

5.  Increased plasma MMP-2 protein expression in lymph node-positive patients with colorectal cancer.

Authors:  Marcus Langenskiöld; Lena Holmdahl; Peter Falk; Marie-Louise Ivarsson
Journal:  Int J Colorectal Dis       Date:  2004-12-08       Impact factor: 2.571

6.  Proteolysis in colorectal cancer.

Authors:  E A Garbett; M W Reed; N J Brown
Journal:  Mol Pathol       Date:  1999-06

7.  Metastatic and non-metastatic colorectal cancer (CRC) cells induce host metalloproteinase production in vivo.

Authors:  S Mc Donnell; V Chaudhry; J Mansilla-Soto; Z S Zeng; W P Shu; J G Guillem
Journal:  Clin Exp Metastasis       Date:  1999-06       Impact factor: 5.150

Review 8.  Matrix metalloproteinase inhibitors in the treatment of cancer.

Authors:  P D Brown
Journal:  Med Oncol       Date:  1997-03       Impact factor: 3.064

9.  Metastatic colorectal cancer cells induce matrix metalloproteinase release by human monocytes.

Authors:  C J Swallow; M P Murray; J G Guillem
Journal:  Clin Exp Metastasis       Date:  1996-01       Impact factor: 5.150

10.  Redistribution of fibroblasts and macrophages as micrometastases develop into established liver metastases.

Authors:  Nobuaki Higashi; Hideki Ishii; Takeshi Fujiwara; Megumi Morimoto-Tomita; Tatsuro Irimura
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.